Women’s and Men’s Reproductive Health Pharma Company Besins Healthcare, has opened a new hormone production facility in Muel, Spain, bolsteing their global hormone production capacity by a 30%. This milestone is a response to the growing worldwide demand for hormones, particularly concerning late pregnancies and menopause. The opening follows Besins Healthcare’s strategic acquisition of a hormone production site in Drogenbos, Belgium, in…
Notify Therapeutics, a biotech company based in Denmark, has raised €5M in funding to advance the development of its innovative non-hormonal fertility treatment. The investment was made by Lundbeckfonden BioCapital and +ND Capital, highlighting their continued commitment to boosting Danish biotech and addressing pressing fertility issues. Founded from research by Professor Karin Lykke-Hartmann into female infertility, Notify Therapeutics is at the forefront…
A recent study published in the Nature demonstrates the potential of CHLOE, an AI decision support technology developed by Fairtility, to advance academic research in reproductive health. The study led by Professor Iris Har Vardi, an authority in the field of fertility and IVF, specifically focused on the impact of blastocyst morphometric parameters on implantation potential. Professor Har Vardi, Director of Fertility…
Austin-based startup Mosie Baby, a pioneer in at-home fertility solutions, has announced the launch of an updated Mosie Baby At-Home Insemination Kit and the successful closing of an oversubscribed bridge round with over $1M in funding. Founded in 2015, Mosie Baby addresses the challenges couples and individuals face when looking for affordable and comfortable fertility solutions. Created by Maureen and Marc Brown,…
Fertility startup Myma Medical has secured an additional £145K from innovation management consultancy LYVA Labs. bringing LYVA Labs’ total support for the UK-based startup to £779K, including grant leverage. Founded as a spinout from the University of Birmingham, Myma Medical is advancing fertility treatments with its patented autoICSI (Intracytoplasmic Sperm Injection) system. The next-gen technology aims to minimize inconsistencies that often occur…
TMRW Life Sciences, a New York-based company specializing in fertility technology has received a CE Mark for its its CryoRobot Select (CRS) platform. This regulatory approval follows the platform’s clearance by the U.S. Food and Drug Administration (FDA) in November 2022, making it compliant for commercial use both in the United States and in CE Mark-required regions, including the EU and the…
Thermo Fisher Scientific has launched two next-generation sequencing-based assays aimed at accelerating research in fertility and reproductive health. These tools are designed to work with the Ion Torrent Genexus Integrated Sequencer and are intended for research use only meaning they are not meant to be used in diagnostic procedures. Based in Carlsbad, California, Thermo Fisher Scientific has introduced the Ion ReproSeq PGT-A…
German healthtech startup Fertilly has recently launched Europe’s first home fertility test that utilizes the dry blood method. This technology allows women to gain precise insights into their fertility health using a few drops of dry blood from the comfort of their homes. The focal point of this test is the measurement of Anti-Müllerian Hormone (AMH) levels, a crucial indicator of ovarian…
